Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 18, 2021

View Archived Issues

Cancer vaccine CVD908ssb-TXSVN enters phase I study for multiple myeloma

Vidutolimod to be studied in triple-negative breast cancer and non-melanoma skin cancer

First patient dosed with CIT-013, a first-in-class antagonist targeting NETs

Complexes cross BBB, knock down CNS genes in rodents

Collaboration announced for phase II study of larazotide for COVID-19-derived MIS-C

Joint venture announcement behind AR-035 and AR-882 development in China

DNMT3a and DNA methylation alterations in the nucleus accumbens are involved in PTSD-like behavior

Sichuan Kelun-Biotech Biopharmaceutical patents TGFR1 inhibitors

Jiangsu Simcere Pharmaceutical presents BTK and JAK3 inhibitors

Enanta Pharmaceuticals synthesizes new antiviral compounds

Sirnaomics describes new siRNAs targeting SARS-CoV-2

Istari Oncology expands LUMINOS-103 trial of PVSRIPO to include HNSCC

Transcenta begins phase II trial of TST-001 in solid tumors

Phase I study of Alzheimer's disease candidate AL-001 to begin in September

Preclinical toxicology study supports development of antidiarrheal lechlemer

Ganaxolone reduces seizure frequency in tuberous sclerosis complex patients

HER2 expression is a prognostic factor in DCIS

Pirfenidone shows favorable effects in patients with HFpEF

ExeVir's COVID-19 treatment and prophylactic XVR-011 enters clinical study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...